Wish you could get rid of your COVID-19 symptoms sooner? The OakTree Study is looking at a potential new oral drug for adolescents and adults with COVID-19 to see if it can shorten the number of days you have symptoms.
Criteria:
To be considered for the study, you must:
- Be 12 to 64 years of age.
- Have tested positive for COVID-19 in the past 3 days.
- Have had COVID-19 symptoms for no more than 3 days.
- NOT be at risk for developing serious disease.
- NOT be currently hospitalized or require hospitalization.
Both vaccinated and unvaccinated people will be considered for this study. If you had a vaccine or booster, you must have received it more than 4 months before starting the study.